4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-045433
Chief Executive Officer sold 1,974 shares at $60.83 ($120,084)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-03-24 | Sale 10b5-1 | −1,974 | $60.83 | $120,084 | 3,017,437 | I |
| Open-market sales · 1,974 sh · avg $60.83 · $120,084 | |||||||
Loading xslF345X05/ownership.xml…